Matt Trudeau | President
ITF Therapeutics

Matt Trudeau, President, ITF Therapeutics

I build and lead high impact, cross-functional teams to bring innovative therapies to patient communities. I’ve been entrusted over a 30-year career to lead value creation across various therapeutic areas, including oncology, gene therapy, neurology, and rare disease. Along this journey, I’ve been lucky to be surrounded by smart, motivated people who share my passion for the work we do and inspire me to reach higher and ask more of myself every day.

Appearances:



Day 1- World Orphan Drug Congress USA 2025 @ 15:30

Presentation: ITF Therapeutics commercial start-up bootcamp: From data to market in six months

Day 2 - World Orphan Drug Congress USA 2025 @ 11:00

Panel: The future of drug development in Rare and Orphan Diseases: Navigating regulatory Challenges and clinical innovation

Sponsored by Lumanity.

last published: 24/Apr/25 11:35 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 
 

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Kaylee Nguyen
kaylee.nguyen@terrapinn.com
 

 

 

 

Marketing & Press

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com